Stay updated on ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial
Sign up to get notified when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.

Latest updates to the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page
- Check3 days agoChange DetectedPrimary Completion Date updated to 2026-12-23 and a new Last Update entry on 2026-04-07 were added. Several older date entries (e.g., 2026-02xx and 2026-04-23) were removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.2 was applied, adding USWM CT, LLC and USWM, LLC (dba US WorldMeds) as sponsors/collaborators. Prior collaborators and IPD sharing plan references were removed.SummaryDifference0.8%

- Check68 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1; no substantive content or functionality changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page adds a glossary toggle and new QC-related metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) and removes the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

Stay in the know with updates to ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.